# Balchem Q3 2026 Earnings Report

> Balchem reports record Q3 earnings with 8.6% revenue growth and 16.0% higher net earnings.
- Title: Balchem Q3 2026 Earnings Report · The Motley Fool | Shortify
- Summary: Balchem reports record Q3 earnings with 8.6% revenue growth and 16.0% higher net earnings. Balchem achieved record Q3 revenue of $290.7 million, 8.6% up from…
- Keywords: balchem, bcpc, earnings, revenue, net earnings, adjusted ebitda, stock repurchases, cash flow, finance, money, 2026, Report
- Source: The Motley Fool — https://fool.com/earnings/call-transcripts/2026/10/23/balchem-bcpc-q3-2026-earnings-call-transcript
- Author: Motley Fool Transcribing
- Published: 2026-10-23T17:53:15+00:00
- Read time: 2 min
- Topics: balchem, bcpc, q3, earnings, revenue, net earnings, adjusted ebitda, stock repurchases, cash flow, finance, money
## Q3 Earnings Results
Balchem reported record Q3 revenue of $290.7 million, an 8.6% increase from the prior year quarter.
## GAAP Net Earnings
GAAP net earnings rose to $46.7 million, a 16.0% increase from the prior year quarter.
## Adjusted EBITDA
Adjusted EBITDA reached $80.3 million, up 12.4% from the prior year quarter with a 27.6% margin.
## Diluted EPS
GAAP diluted earnings per share increased to $1.46, a 17.7% rise from the prior year quarter.
## Gross Margin
Gross margin expanded to 36.4%, a 70 basis point improvement driven by sales growth and favorable product mix.
## Human Nutrition Segment
Human nutrition and health revenue grew 8.1% to $188.2 million driven by nutrients and food ingredients businesses.
## Animal Nutrition Segment
Animal nutrition and health revenue increased 11.7% to $63.0 million from higher sales in monogastric and ruminant markets.
## Specialty Products
Specialty products revenue rose 4.5% to $37.3 million due to performance gases business growth.
## Operating Expenses
Operating expenses rose to $43.3 million, primarily due to higher compensation-related costs.
## Free Cash Flow
Free cash flow reached $57.9 million, supporting capital allocation and growth investments.
## Cash Balance
Cash balance stood at $66.3 million as of Sept. 30, 2026, including $28 million debt reduction and $28 million share repurchases.
## Net Debt
Net debt was $57.7 million with a net leverage ratio of 0.2 times trailing 12-month adjusted EBITDA.
## Inventories
Inventories increased to $177.0 million, reflecting inflation, volume growth, and deliberate safety stock builds.
## Net Interest Expense
Net interest expense decreased to $1.9 million from $2.6 million in the prior year quarter.
## Effective Tax Rate
Effective tax rate dropped to 22.2%, a decrease from 22.6% in the prior year quarter.
## 29th Consecutive Q Growth
Balchem achieved its 29th consecutive quarter of year-over-year growth in adjusted EBITDA.
## Key takeaway

Balchem achieved record Q3 revenue of $290.7 million, 8.6% up from prior year, with 16.0% higher GAAP net earnings.